| Related Articles |
Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-Label Clinical Trial.
JAMA Psychiatry. 2020 Nov 04;:
Authors: Dahlgren MK, Sagar KA, Lambros AM, Smith RT, Gruber SA
PMID: 33146684 [PubMed – as supplied by publisher]
Source: ncbi